GlassScriptPhysician profile
Frank A Luckino
NPI 1801187570
$16,917.44
in general payments reported to CMS, 2019-2025
34 companies · $656 in 2025
The $656 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,865 · 2020: $764 · 2021: $6,039 · 2022: $3,738 · 2023: $366 · 2024: $490 · 2025: $656.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,512.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,511.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rock Medical Orthopedics, INC. | $7,898.33 | 2019-2023 | |
| Arthrex, INC. | $4,315.76 | 2021-2022 | |
| Organogenesis INC. | $1,355.54 | 2019-2024 | Puraply Wound Matrix, Puraply |
| Smith+Nephew, INC. | $953.24 | 2019-2025 | Pico, Stravix, Collagenase Santyl |
| Kerecis Limited | $296.21 | 2021-2025 | Kerecis Surgiclose, Kerecis Graftguide, Kerecis Omega3 Marigen |
| Paratek Pharmaceuticals, INC. | $255.65 | 2023-2025 | Nuzyra |
| Horizon Therapeutics Plc | $216.36 | 2020-2023 | Krystexxa |
| Kci USA, INC. | $186.16 | 2019-2023 | Activ.A.C. |
| Melinta Therapeutics, LLC | $159.70 | 2020-2022 | |
| Integra Lifesciences Corporation | $153.81 | 2019-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Stryker Corporation | $139.83 | 2019-2023 | Citrefix, 7 X 23mm Citrelock Implant, Ortholoc 3di |
| Zimmer Biomet Holdings, INC. | $99.49 | 2019-2020 | |
| Phathom Pharmaceuticals, INC. | $99.39 | 2025 | Voquezna |
| Paragon 28, INC. | $93.01 | 2024 | Ttc Nail |
| Misonix INC | $76.76 | 2020-2021 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $74.79 | 2023-2025 | |
| Bioventus LLC | $70.64 | 2022-2024 | Exogen Ultrasound Bone Healing System, Theragenesis Bilayer Wound Matrix |
| Treace Medical Concepts, INC. | $69.61 | 2023-2024 | |
| Amgen INC. | $48.98 | 2024-2025 | Krystexxa |
| Medtronic, INC. | $47.17 | 2022-2025 | Inceptiv |
| Kowa Pharmaceuticals America, INC. | $39.78 | 2022-2023 | Seglentis |
| Merck Sharp & Dohme LLC | $36.33 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $33.92 | 2025 | |
| Tactile Systems Technology INC | $29.29 | 2022-2025 | Flexitouch Plus, Nimbl |
| Nexus Medical Technologies LLC | $27.13 | 2024 | |
| Triad Life Sciences INC. | $25.70 | 2022 | |
| Orthofix Medical, INC. | $19.79 | 2023 | Physio-Stim |
| Baudax Bio INC. | $18.48 | 2022 | |
| Solventum Corporation | $18.45 | 2025 | Activ.A.C. |
| Mimedx Group, INC. | $16.69 | 2025 | |
| Osteomed LLC | $13.80 | 2019 | |
| Abbott Laboratories | $12.66 | 2021 | |
| Acell, INC. | $11.41 | 2019 | |
| Microaire Surgical Instruments LLC | $3.58 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frank Luckino listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.